Skip to main content
Top
Published in: International Urology and Nephrology 7/2019

01-07-2019 | Eclampsia | Nephrology - Original Paper

Acute kidney injury in patients with HELLP syndrome

Authors: Wenling Ye, Hong Shu, Yang Yu, Hang Li, Limeng Chen, Juntao Liu, Xue-mei Li

Published in: International Urology and Nephrology | Issue 7/2019

Login to get access

Abstract

Purpose

To evaluate the risk factors and renal prognosis of acute kidney injury (AKI) in patients with hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome.

Methods

Women with HELLP syndrome over a 15-year period at Peking Union Medical College Hospital, China, were retrospectively studied.

Results

A total of 108 patients with HELLP syndrome were included. Fifty-two (48.1%) patients were diagnosed with AKI (median serum creatinine, 139.72 µmol/L; range, 89.00–866.00); 11 (21.2%) required hemodialysis. The AKI group had significantly more multiparity (p = 0.034), hemorrhage > 400 mL (p = 0.027), severe systolic hypertension ≥ 160 mmHg (p = 0.005), infection (p < 0.001), and low hemoglobin (p = 0.002) than non-AKI patients. Multivariate logistic regression showed that infection (OR 36.441, 95% CI 3.819–347.732, p = 0.002), severe systolic hypertension (OR 5.295, 95% CI 1.795–15.620, p = 0.003), and low hemoglobin (OR 0.960, 95% CI 0.932–0.988, p = 0.006) were independent risk factors for AKI. Six patients with AKI died (mortality rate: 11.5%); no death occurred among patients without AKI. In addition to infection (OR 16.268, CI 1.334–198.385, p = 0.029) and eclampsia (OR 69.895, CI 2.834–1723.910, p = 0.009), elevated serum creatinine (OR 1.006, CI 1.001–1.011, p = 0.031) was an independent predictor of maternal mortality. Renal function in 43 (82.7%) patients completely recovered. Two (3.8%) patients developed chronic renal dysfunction after 1 to 2 years of follow-up.

Conclusions

Elevated creatinine was an independent predictor of maternal mortality in HELLP syndrome. AKI severely affects renal prognosis and mortality in pregnant women. The occurrence of AKI was related to infection, severe hypertension, and renal ischemia.
Literature
2.
go back to reference Erdemoglu M, Kuyumcuoglu U, Kale A, Akdeniz N (2010) Factors affecting maternal and perinatal outcomes in HELLP syndrome: evaluation of 126 cases. Clin Exp Obstet Gynecol 37(3):213–216PubMed Erdemoglu M, Kuyumcuoglu U, Kale A, Akdeniz N (2010) Factors affecting maternal and perinatal outcomes in HELLP syndrome: evaluation of 126 cases. Clin Exp Obstet Gynecol 37(3):213–216PubMed
6.
go back to reference Abraham KA, Connolly G, Farrell J, Walshe JJ (2001) The HELLP syndrome, a prospective study. Renal Fail 23(5):705–713CrossRef Abraham KA, Connolly G, Farrell J, Walshe JJ (2001) The HELLP syndrome, a prospective study. Renal Fail 23(5):705–713CrossRef
8.
go back to reference Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169(4):1000–1006CrossRefPubMed Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169(4):1000–1006CrossRefPubMed
9.
go back to reference Gul A, Aslan H, Cebeci A, Polat I, Ulusoy S, Ceylan Y (2004) Maternal and fetal outcomes in HELLP syndrome complicated with acute renal failure. Renal Fail 26(5):557–562CrossRef Gul A, Aslan H, Cebeci A, Polat I, Ulusoy S, Ceylan Y (2004) Maternal and fetal outcomes in HELLP syndrome complicated with acute renal failure. Renal Fail 26(5):557–562CrossRef
10.
go back to reference Martinez de Ita AL, Garcia Caceres E, Helguera Martinez AM, Cejudo Carranza E (1998) Acute renal insufficiency in HELLP syndrome. Ginecologia y obstetricia de Mexico 66:462–468PubMed Martinez de Ita AL, Garcia Caceres E, Helguera Martinez AM, Cejudo Carranza E (1998) Acute renal insufficiency in HELLP syndrome. Ginecologia y obstetricia de Mexico 66:462–468PubMed
12.
go back to reference Selcuk NY, Odabas AR, Cetinkaya R, Tonbul HZ, San A (2000) Outcome of pregnancies with HELLP syndrome complicated by acute renal failure (1989–1999). Renal Fail 22(3):319–327CrossRef Selcuk NY, Odabas AR, Cetinkaya R, Tonbul HZ, San A (2000) Outcome of pregnancies with HELLP syndrome complicated by acute renal failure (1989–1999). Renal Fail 22(3):319–327CrossRef
13.
go back to reference Drakeley AJ, Le Roux PA, Anthony J, Penny J (2002) Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol 186(2):253–256CrossRefPubMed Drakeley AJ, Le Roux PA, Anthony J, Penny J (2002) Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol 186(2):253–256CrossRefPubMed
14.
go back to reference Randeree IG, Czarnocki A, Moodley J, Seedat YK, Naiker IP (1995) Acute renal failure in pregnancy in South Africa. Renal Fail 17(2):147–153CrossRef Randeree IG, Czarnocki A, Moodley J, Seedat YK, Naiker IP (1995) Acute renal failure in pregnancy in South Africa. Renal Fail 17(2):147–153CrossRef
16.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int 2(Suppl):1–138 Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int 2(Suppl):1–138
19.
go back to reference Sibai BM, Ramadan MK (1993) Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol 168(6 Pt 1):1682–1687; discussion 1687–1690CrossRefPubMed Sibai BM, Ramadan MK (1993) Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol 168(6 Pt 1):1682–1687; discussion 1687–1690CrossRefPubMed
20.
go back to reference Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM (1999) Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 180(1 Pt 1):221–225CrossRefPubMed Abramovici D, Friedman SA, Mercer BM, Audibert F, Kao L, Sibai BM (1999) Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 180(1 Pt 1):221–225CrossRefPubMed
27.
go back to reference Aggarwal RS, Mishra VV, Jasani AF, Gumber M (2014) Acute renal failure in pregnancy: our experience. Saudi J Kidney Dis Transpl 25(2):450–455CrossRefPubMed Aggarwal RS, Mishra VV, Jasani AF, Gumber M (2014) Acute renal failure in pregnancy: our experience. Saudi J Kidney Dis Transpl 25(2):450–455CrossRefPubMed
Metadata
Title
Acute kidney injury in patients with HELLP syndrome
Authors
Wenling Ye
Hong Shu
Yang Yu
Hang Li
Limeng Chen
Juntao Liu
Xue-mei Li
Publication date
01-07-2019
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 7/2019
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02111-7

Other articles of this Issue 7/2019

International Urology and Nephrology 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.